Back

Multi-organ sonographic assessment of congestion has incremental prognostic value in outpatients with heart failure irrespective of left ventricular ejection fraction

13 April 2023 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Secondary Prevention and Rehabilitation 1 Imaging EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Assistant Professor Nicola Riccardo Pugliese

Pisa University Hospital, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Usefulness of heart failure categories based on left ventricular ejection fraction
Mrs M. Christersson (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Left atrial mechanics and functional capacity in HFpEF patients with paroxysmal atrial fibrillation
Doctor A. Katbeh (Damascus, SY)
Abstract Slides Video
Presentation thumbnail
Left atrial strain as an independent predictor of sinus rhythm maintenance after catheter ablation for paroxysmal atrial fibrillation in HFpEF patients
Doctor A. Katbeh (Damascus, SY)
Abstract Slides Video
Presentation thumbnail
Sex differences in the change in cardiorespiratory fitness and quality of life following exercise training in adults with atrial fibrillation: a systematic review and meta-analysis
Miss S. Vidal Almela (Granada, ES)
Abstract Slides Video
Presentation thumbnail
Nitric oxide metabolites in heart failure patients with reduced or preserved ejection fraction and effects of different exercise modes
Miss S. Dinges (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary Prevention and Rehabilitation 1
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April - 15 April 2023
You may be interested in
thumbnail
Congress Presentation
Hemodynamic evaluation of right-sided congestion with doppler ultrasonography in pulmonary hypertension: portal vs intra-renal venous flow patterns
thumbnail
Congress Presentation
How to best assess congestion with ultrasound?
thumbnail
Congress Presentation
How to assess congestion and response to treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources